Philips Respironics Announces Availability of New Patient-Centric Solution for the Management of Chronic Respiratory Insufficiency Diseases, BiPAP A40, on World COPD Day 2012

Philips Respironics Announces Availability of New Patient- Centric Solution for the Management of Chronic Respiratory Insufficiency Diseases, BiPAP A40, on World COPD Day 2012 PR Newswire DÜSSELDORF, Germany, November 14, 2012 DÜSSELDORF, Germany, November 14, 2012 /PRNewswire/ -- BiPAP A40 is a new multi-modality bi-level ventilator featuring the first fully automatic ventilation mode, designed to support the smooth transition of treatment from hospital to home [1]Philips Respironics today announces the availability of the new bi-level ventilator BiPAP A40 for the management of chronic respiratory insufficiency, a condition secondary to diseases such as obesity hypoventilation syndrome, chronic obstructive pulmonary disease (COPD) and neuromuscular disease for adult and pediatric patients (above 10 kg). Launching on World COPD Day 2012 and being showcased this week at Medica 2012, the world's largest medical trade fair, the BiPAP A40 improves the management of chronic respiratory diseases by offering a range of unique benefits that facilitate the smoothest possible transition in the patient care pathway - from initial titration to hospital discharge, from home therapy to long-term follow-up. "Philips is proud to be able to provide access to new and innovative solutions that improve quality of care for respiratory patients - both in hospital and at home," comments Mats Dahlquist, general manager international, Philips Home Healthcare Solutions.